Vista Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Vista Investment Partners's BMY Position: Q2 2026 in Review
Vista Investment Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.94% in Q2 2026, selling an estimated $3.16K and leaving 5,786 shares worth $333K. The position accounts for 0.08% of the portfolio, ranked #138.
Vista Investment Partners first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.57M in Q1 2024. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Vista Investment Partners held 5,786 shares of Bristol-Myers Squibb worth $333K as of Q2 2026.
- Vista Investment Partners sold 55 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.16K.
- Bristol-Myers Squibb made up 0.08% of Vista Investment Partners's portfolio in Q2 2026, its #138 holding.
- Vista Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Vista Investment Partners's Bristol-Myers Squibb position peaked at $1.57M in Q1 2024.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Vista Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.